A global survey about undiagnosed rare diseases: perspectives, challenges, and solutions
Open Access
- 26 February 2025
- journal article
- public health
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1510818
Abstract
Background: Undiagnosed rare diseases (URDs) are a complex and multifaceted challenge, especially in low-and medium-income countries. They affect individuals with unique clinical features and lack a clear diagnostic label. Although the Undiagnosed Diseases Network International (UDNI) definition of URDs is not universally accepted, it is widely recognized.Methods: We surveyed UDNI members and participants from other countries to explore the challenges posed by URDs and identify possible solutions. Participation in the survey was completely voluntary.Results: The survey revealed a need for more consensus on a universally accepted definition for URDs. Still, the UDNI definition gained widespread recognition and serves as a valuable framework for understanding and addressing the challenges of URDs. In addition to national or international networks, fostering a more substantial engagement and resource-sharing ethos among member countries is critical. Despite advances in genomics and diagnostic tools, the diagnostic journey for people living with URDs (PLURDs) remains arduous and often inconclusive. The availability of specialized centers and the utilization of whole exome sequencing (WES) and whole genome sequencing (WGS) vary across countries, with disparities due to healthcare systems, economic status, and government policies. Advocacy groups play a crucial role in supporting PLURDs.Conclusion: A unified commitment to prioritizing URDs on the global health agenda, paired with targeted funding, stipulated national strategies, and aligned international cooperation, is imperative to leveling the playing field for the diagnosis and management of URDs and capitalizing on the potential of Advocacy Groups as allies in this endeavor.Keywords
This publication has 21 references indexed in Scilit:
- Rare diseases: challenges and opportunities for research and public healthNature Reviews Disease Primers, 2024
- Personalized medicine is having its dayNature Biotechnology, 2023
- Meeting the needs of patients with ultrarare diseasesTrends in Molecular Medicine, 2022
- Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experienceJournal Of Nephrology, 2020
- How many rare diseases are there?Nature Reviews Drug Discovery, 2019
- Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet databaseEuropean Journal of Human Genetics, 2019
- Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needsMolecular Genetics and Metabolism, 2015
- Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupValue in Health, 2015
- Neglected DiseasesNature, 2007
- A journey of hope: lessons learned from studies on rare diseases and orphan drugsJournal of Internal Medicine, 2006